We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

120 hedge funds and large institutions have $214M invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q2 according to their latest regulatory filings, with 120 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more call options, than puts

Call options by funds: $9.83M | Put options by funds: $9.7M

Holders
120
Holders Change
+120
Holders Change %
–
% of All Funds
3.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
120
Increased
–
Reduced
–
Closed
–
Calls
$9.83M
Puts
$9.7M
Net Calls
+$126K
Net Calls Change
+$126K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
1
State Street
Massachusetts
$22M +$28.8M +5,350,612 New
BIT
2
BlackRock Institutional Trust
California
$16.3M +$21.4M +3,975,292 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$14.2M +$18.5M +3,444,917 New
BFA
4
BlackRock Fund Advisors
California
$13.5M +$17.7M +3,288,629 New
O
5
OrbiMed
New York
$13.4M +$17.5M +3,256,100 New
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$12.2M +$16M +2,969,281 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$9.87M +$12.9M +2,402,524 New
Franklin Resources
8
Franklin Resources
California
$6.8M +$8.89M +1,654,000 New
PA
9
Perceptive Advisors
New York
$6.78M +$8.87M +1,649,423 New
Invesco
10
Invesco
Georgia
$5.65M +$7.4M +1,375,742 New
Northern Trust
11
Northern Trust
Illinois
$5.27M +$6.89M +1,281,649 New
Ameriprise
12
Ameriprise
Minnesota
$4.94M +$6.46M +1,201,174 New
BIM
13
Bogle Investment Management
Massachusetts
$4.82M +$6.31M +1,173,119 New
OAM
14
Oxford Asset Management
United Kingdom
$4.43M +$5.8M +1,078,743 New
Renaissance Technologies
15
Renaissance Technologies
New York
$3.95M +$5.17M +962,071 New
SBH
16
Segall Bryant & Hamill
Illinois
$3.6M +$4.71M +875,142 New
Morgan Stanley
17
Morgan Stanley
New York
$3.27M +$4.27M +794,361 New
JGC
18
J. Goldman & Co
New York
$3.19M +$4.17M +775,000 New
PCP
19
Perimeter Capital Partners
Georgia
$3.17M +$4.14M +770,661 New
Citadel Advisors
20
Citadel Advisors
Florida
$2.79M +$3.65M +678,079 New
Deutsche Bank
21
Deutsche Bank
Germany
$2.75M +$3.61M +670,534 New
IGIM
22
I.G. Investment Management
Manitoba, Canada
$2.23M +$2.92M +542,500 New
Goldman Sachs
23
Goldman Sachs
New York
$2.03M +$2.66M +494,015 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$2.02M +$2.64M +490,222 New
Millennium Management
25
Millennium Management
New York
$1.88M +$2.46M +458,314 New
1
2 3 4 5

ASTX Hedge Fund Activity: Q2 2013 in Review

120 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q2 2013, worth a combined $214M.

Buyers outnumbered sellers: 120 funds opened new ASTX positions and 0 closed out — a net gain of 120 holders — while 0 added to existing stakes and 0 trimmed.

  • 120 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $214M of ASTEX PHARMACEUTICALS, INC COM stock for Q2 2013.
  • 120 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q2 2013 and 0 closed out, a net change of +120 holders.

Based on aggregated 13F filings for Q2 2013.